 In a report released today,Ram Selvarajufrom H.C. Wainwright reiterated aHoldrating on Intec Pharma NTECResearch Report. The companys shares closed last Thursday at 0.21, close to its 52-week low of 0.14.According toTipRanks.com, Sel 